Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
mRNA technology represents a cutting-edge therapeutic approach, utilizing messenger RNA to direct cells in manufacturing specific proteins essential for a variety of medical applications, including vaccines and gene therapies.
The rapid development and authorization of mRNA-based vaccines during the COVID-19 pandemic sparked renewed interest in this advanced technology, leading to market constraints on critical raw materials and manufacturing capacity.
Thermo Fisher Scientific has responded by implementing a flexible solutions model for mRNA vaccine and therapeutic development, covering the entire operational value chain, from early translational services to cold chain logistics.
Whether you require support with refining processes or adhering to cGMP standards, you have the flexibility to choose from our core mRNA service offerings and integrate additional upstream and downstream solutions as needed.
Download our fact sheet to learn more about Therma Fisher Scientific’s development and manufacturing services for mRNA.